Bijan Ahvazi

Array ( [id] => 6039475 [patent_doc_number] => 20110092524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'Agent for Enhancing Corneal Epithelial Barrier Function' [patent_app_type] => utility [patent_app_number] => 12/866625 [patent_app_country] => US [patent_app_date] => 2009-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3253 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092524.pdf [firstpage_image] =>[orig_patent_app_number] => 12866625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6196803 [patent_doc_number] => 20110028561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'PROTECTION OF NEURAL RETINA BY REDUCTION OF ROD METABOLISM' [patent_app_type] => utility [patent_app_number] => 12/867931 [patent_app_country] => US [patent_app_date] => 2009-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13221 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028561.pdf [firstpage_image] =>[orig_patent_app_number] => 12867931 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5392261 [patent_doc_number] => 20090209574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'FLUOROQUINOLONE DERIVATIVES FOR OPHTHALMIC APPLICATIONS' [patent_app_type] => utility [patent_app_number] => 12/371880 [patent_app_country] => US [patent_app_date] => 2009-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4678 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209574.pdf [firstpage_image] =>[orig_patent_app_number] => 12371880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5458902 [patent_doc_number] => 20090259054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'Methods and Compositions for the Treatment of Angiogenesis and Macular Degeneration' [patent_app_type] => utility [patent_app_number] => 12/359910 [patent_app_country] => US [patent_app_date] => 2009-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 12916 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0259/20090259054.pdf [firstpage_image] =>[orig_patent_app_number] => 12359910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5404633 [patent_doc_number] => 20090239947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-24 [patent_title] => 'Inhibition of proliferation and fibrotic response of activated corneal stromal cells' [patent_app_type] => utility [patent_app_number] => 12/321812 [patent_app_country] => US [patent_app_date] => 2009-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 10675 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0239/20090239947.pdf [firstpage_image] =>[orig_patent_app_number] => 12321812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6071364 [patent_doc_number] => 20110046215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'ABNORMAL INTRAOCULAR PRESSURE TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/863073 [patent_app_country] => US [patent_app_date] => 2009-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2574 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046215.pdf [firstpage_image] =>[orig_patent_app_number] => 12863073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5423090 [patent_doc_number] => 20090149546 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-11 [patent_title] => 'Enhanced Bimatoprost Ophthalmic Solution' [patent_app_type] => utility [patent_app_number] => 12/351383 [patent_app_country] => US [patent_app_date] => 2009-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2128 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20090149546.pdf [firstpage_image] =>[orig_patent_app_number] => 12351383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6455847 [patent_doc_number] => 20100105734 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-29 [patent_title] => 'Treatment xerophthalmia with norketotifen' [patent_app_type] => utility [patent_app_number] => 12/317575 [patent_app_country] => US [patent_app_date] => 2008-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6305 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20100105734.pdf [firstpage_image] =>[orig_patent_app_number] => 12317575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5538769 [patent_doc_number] => 20090220574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'SURAMIN AND DERIVATIVES THEREOF AS TOPICAL MICROBICIDE AND CONTRACEPTIVE' [patent_app_type] => utility [patent_app_number] => 12/340339 [patent_app_country] => US [patent_app_date] => 2008-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 13523 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20090220574.pdf [firstpage_image] =>[orig_patent_app_number] => 12340339 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10505218 [patent_doc_number] => 09233078 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-12 [patent_title] => 'Nanoparticles comprising a non-ionizable polymer and an Amine-functionalized methacrylate copolymer' [patent_app_type] => utility [patent_app_number] => 12/746752 [patent_app_country] => US [patent_app_date] => 2008-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14037 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12746752 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6603108 [patent_doc_number] => 20100323023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-23 [patent_title] => 'COMPOSITION FOR THE TREATMENT OF A DETACHED RETINA AND METHOD OF PRODUCTION THEREOF' [patent_app_type] => utility [patent_app_number] => 12/811566 [patent_app_country] => US [patent_app_date] => 2008-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3143 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0323/20100323023.pdf [firstpage_image] =>[orig_patent_app_number] => 12811566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5564686 [patent_doc_number] => 20090137539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'TOPICAL OPHTHALMIC OR OTIC SOLUTION FORMULATIONS CONTAINING MOXIFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE PHOSPHATE' [patent_app_type] => utility [patent_app_number] => 12/276823 [patent_app_country] => US [patent_app_date] => 2008-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4576 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20090137539.pdf [firstpage_image] =>[orig_patent_app_number] => 12276823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5279317 [patent_doc_number] => 20090131449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'USE OF TRPV1 RECEPTOR ANTAGONISTS FOR TREATING DRY EYE AND OCULAR PAIN' [patent_app_type] => utility [patent_app_number] => 12/273047 [patent_app_country] => US [patent_app_date] => 2008-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4572 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131449.pdf [firstpage_image] =>[orig_patent_app_number] => 12273047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5552732 [patent_doc_number] => 20090286718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'Stable Aqueous Cyclosporin Compositions' [patent_app_type] => utility [patent_app_number] => 12/272445 [patent_app_country] => US [patent_app_date] => 2008-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7114 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20090286718.pdf [firstpage_image] =>[orig_patent_app_number] => 12272445 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5386432 [patent_doc_number] => 20090227677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'Low Dose Lipoic Acid Pharmaceutical Compositions and Methods' [patent_app_type] => utility [patent_app_number] => 12/267208 [patent_app_country] => US [patent_app_date] => 2008-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4550 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20090227677.pdf [firstpage_image] =>[orig_patent_app_number] => 12267208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9375814 [patent_doc_number] => 08680078 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-25 [patent_title] => 'Stable ophthalmic formulations' [patent_app_type] => utility [patent_app_number] => 12/936640 [patent_app_country] => US [patent_app_date] => 2008-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10121 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12936640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6137131 [patent_doc_number] => 20110009488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'Lipoxin A4 Protection for Cornea Endothelial Cells' [patent_app_type] => utility [patent_app_number] => 12/740413 [patent_app_country] => US [patent_app_date] => 2008-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 3592 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009488.pdf [firstpage_image] =>[orig_patent_app_number] => 12740413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5279272 [patent_doc_number] => 20090131404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Combinations' [patent_app_type] => utility [patent_app_number] => 12/290106 [patent_app_country] => US [patent_app_date] => 2008-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5070 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131404.pdf [firstpage_image] =>[orig_patent_app_number] => 12290106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6496940 [patent_doc_number] => 20100286121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Water-Immiscible Materials as Vehicles for Drug Delivery' [patent_app_type] => utility [patent_app_number] => 12/741266 [patent_app_country] => US [patent_app_date] => 2008-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6415 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286121.pdf [firstpage_image] =>[orig_patent_app_number] => 12741266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5440936 [patent_doc_number] => 20090092575 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'OPHTHALMIC COMPOSITIONS WITH A DISUCCINATE' [patent_app_type] => utility [patent_app_number] => 12/246522 [patent_app_country] => US [patent_app_date] => 2008-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5256 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20090092575.pdf [firstpage_image] =>[orig_patent_app_number] => 12246522 [rel_patent_id] =>[rel_patent_doc_number] =>)